Trials / Recruiting
RecruitingNCT07008001
Assessment of DOT Spectacles in Chinese Children Extension
Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 175 (estimated)
- Sponsor
- SightGlass Vision, Inc. · Industry
- Sex
- All
- Age
- 8 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Novel spectacle lens design | Use of spectacle lenses may reduce the rate of progression of juvenile myopia |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2026-09-30
- Completion
- 2026-12-31
- First posted
- 2025-06-06
- Last updated
- 2025-12-29
Locations
5 sites across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07008001. Inclusion in this directory is not an endorsement.